Lymphatic and/or blood vessel invasion in gastric cancer: Relationship with clinicopathological parameters, biological factors and prognostic significance

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 2, 2008, Pages 153-161

  Del Casar, José M ^a   Corte, María D ^a,b   Álvarez, Ana ^c   García, Isabel ^c   Bongera, Miguel ^a   González, Luis O ^a,b   García Muñiz, José L ^c   Allende, María T ^b,c   Astudillo, Aurora ^b   Vizoso, Francisco J ^a,b  

^a HOSPITAL DE JOVE   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Gastric cancer; Prognosis; Tumoral invasion

Indexed keywords

BIOLOGICAL FACTOR; C ERBB 2 PROTEIN; CATHEPSIN D; CD34 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT; HYALURONIC ACID; PROTEIN PS2; RADIOLIGAND; TPA PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; BLOOD VESSEL; CANCER INVASION; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNORADIOMETRIC ASSAY; LYMPH NODE METASTASIS; MALE; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; RADIOASSAY; STAINING; STATISTICAL ANALYSIS; STOMACH CANCER; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; BLOOD VESSELS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; STOMACH NEOPLASMS; SURVIVAL RATE; TISSUE PLASMINOGEN ACTIVATOR; TUMOR MARKERS, BIOLOGICAL;

EID: 36849029764     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-007-0264-3     Document Type: Article

References (48)

1. Arigami T, Natsugoe S, Uenosono Y et al (2005) Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer. Br J Cancer 93:688-693
2. Becker KF, Keller G, Hoefler H (2000) The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg Oncol 9:5-11
3. Boring CC, Squires TS, Tong T (1993) Cancer statistics, 1993. CA Cancer J Clin 43:7-26
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
5. Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395
6. Carmeliet P (2005) VEGF as a key mediator of angiogenesis in cancer. Oncology 69(Suppl 3):4-10
7. Dhar DK, Wang TC, Maruyama R et al (2003) Expression of cytoplasmic TFF2 is a marker of tumor metastasis and negative prognostic factor in gastric cancer. Lab Invest 83:1343-1352
8. Dicken BJ, Graham K, Hamilton SM et al (2006) Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques. Ann Surg 243:64-73
9. Duraker N, Sisman S, Can G (2003) The significance of perineural invasion as a prognostic factor in patients with gastric carcinoma. Surg Today 33:95-100
10. Ferrara N (2002) VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2:795-803
11. Formento JL, Francoual M, Formento P et al (1991) Epidermal growth factor receptor assay: validation of a single point method and application to breast cancer. Breast Cancer Res Treat 17:211-219
12. Gabbert HE, Meier S, Gerharz CD, Hommel G (1991) Incidence and prognostic significance of vascular invasion in 529 gastric-cancer patients. Int J Cancer 49:203-207
13. Garcia I, del Casar JM, Corte MD et al (2003a) Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC R1 or R2) gastric cancer. Int J Biol Markers 18:200-206
14. Garcia I, Vizoso F, Martin A et al (2003b) Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer. Ann Surg Oncol 10:234-241
15. Guadagni S, Reed PI, Johnston BJ et al (1993) Early gastric cancer: follow-up after gastrectomy in 159 patients. Br J Surg 80:325-328
16. Hermaneck P, Sobin L (2002) UICC TNM classification of malignant tumors, 6th edn. Springer, Berlín
17. Hyung WJ, Lee JH, Choi SH, Min JS, Noh SH (2002) Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol 9:562-567
18. Inada K, Shimokawa K, Ikeda T, Ozeki Y (1990) The clinical significance of venous invasion in cancer of the stomach. Jpn J Surg 20:545-552
19. Ishigami S, Natsugoe S, Hokita S et al (1999) Carcinomatous lymphatic invasion in early gastric cancer invading into the submucosa. Ann Surg Oncol 6:286-289
20. Kanai T, Konno H, Maruyama K et al (1997) p53 overexpression and proliferative activity do not correlate with lymph node metastasis in early gastric cancer. Eur Surg Res 29:35-41
21. Kim JP, Hur YS, Yang HK (1995) Lymph node metastasis as a significant prognostic factor in early gastric cancer: analysis of 1,136 early gastric cancers. Ann Surg Oncol 2:308-313
22. Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK (1998) Clinicopathologic characteristics and prognostic factors in 10,783 patients with gastric cancer. Gastric Cancer 1:125-133
23. Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS (2003) Biologic predictors of survival in node-negative gastric cancer. Ann Surg 237:828-835 (discussion 835-837)
24. Kosaka Y, Mimori K, Fukagawa T et al (2007) Identification of the high-risk group for metastasis of gastric cancer cases by vascular endothelial growth factor receptor-1 overexpression in peripheral blood. Br J Cancer 96:1723-1728
25. Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31-49
26. Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK (2000) Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60:4324-4327
27. Maehara Y, Oshiro T, Baba H et al (1995) Lymphatic invasion and potential for tumor growth and metastasis in patients with gastric cancer. Surgery 117:380-385
28. Manuel Del Casar J, Vizoso FJ, Abdel-Laa O et al (2004) Prognostic value of cytosolyc cathepsin D content in resectable gastric cancer. J Surg Oncol 86:16-21
29. Marchalonis JJ (1969) An enzymic method for the trace iodination of immunoglobulins and other proteins. Biochem J 113:299-305
30. Noguchi Y (1990) Blood vessel invasion in gastric carcinoma. Surgery 107:140-148
31. Padera TP, Kadambi A, di Tomaso E et al (2002) Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296:1883-1886
32. Perrot L, Champault G (1998) [What's new in cancer of the stomach? An overview of the literature of this year]. J Chir (Paris) 135:148-154
33. von Rahden BH, Stein HJ, Feith M, Becker K, Siewert JR (2005) Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction. J Clin Oncol 23:874-879
34. Raigoso P, Junco A, Andicoechea A et al (2000) Tissue-type plasminogen activator (tPA) content in colorectal cancer and in surrounding mucosa: relationship with clinicopathologic parameters and prognostic significance. Int J Biol Markers 15:44-50
35. Schoppmann SF, Birner P, Studer P, Breiteneder-Geleff S (2001) Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Anticancer Res 21:2351-2355
36. Schoppmann SF, Bayer G, Aumayr K et al (2004) Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 240:306-312
37. Setala LP, Kosma VM, Marin S et al (1996) Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer 74:766-772
38. Siewert JR, Bottcher K, Roder JD et al (1993) Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg 80:1015-1018
39. Siewert JR, Bottcher K, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228:449-461
40. Suarez C, Vizoso F, Rodriguez JC et al (2001) Prognostic significance of cytosolic pS2 protein content in gastric cancer. Int J Biol Markers 16:37-44
41. Sugarbaker PH (1996) Peritonectomy procedures. Cancer Treat Res 82:235-253
42. Talamonti MS, Kim SP, Yao KA et al (2003) Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery 134:720-727 (discussion 727-729)
43. Tanaka A, Watanabe T, Okuno K, Yasutomi M (1994) Perineural invasion as a predictor of recurrence of gastric cancer. Cancer 73:550-555
44. Vizoso FJ, del Casar JM, Corte MD et al (2004a) Significance of cytosolic hyaluronan levels in gastric cancer. Eur J Surg Oncol 30:318-324
45. Vizoso FJ, Corte MD, Alvarez A et al (2004b) Membranous levels of c-erbB-2 oncoprotein in gastric cancer: their relationship with clinicopathological parameters and their prognostic significance. Int J Biol Markers 19:268-274
46. Yokota T, Kunii Y, Teshima S et al (1999) Significant prognostic factors in patients with node-negative gastric cancer. Int Surg 84:331-336
47. Yokota T, Kunii Y, Teshima S et al (2000) Significant prognostic factors in patients with early gastric cancer. Int Surg 85:286-290
48. Zhang H, Wu J, Meng L, Shou CC (2002) Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells. World J Gastroenterol 8:994-998